Using MoblO2 to maintain oxygen levels during activity
Part of Lungs & breathing clinical trials.
This study tests a device called MoblO2 to help people with COPD or interstitial lung disease keep their oxygen levels up during activity. If you normally use oxygen when you walk or exert yourself, this might help you stay active more safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have COPD or a chronic lung condition that causes scarring of the lungs (interstitial lung disease).
- You’ve been prescribed oxygen to use during activity for at least 1 month.
- You are 25 years old or older.
- Your breathing and oxygen needs have been stable for the past 2 weeks.
- You agree to use compressed oxygen tanks (not a portable concentrator) during the 2-week study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device that tracks how often you use your home oxygen therapy. It is for people with COPD who use oxygen continuously at home and have been medically stable for at least 6 weeks.
This trial tests a new portable oxygen device to help people with lung disease stay active without running out of breath. It compares how well the device works during daily activities.
This study tests whether using portable oxygen during everyday activities helps people with certain lung diseases (like pulmonary fibrosis or COPD) who only experience low oxygen levels when moving around. Researchers want to see if a portable oxygen device improves how well participants can function and feel during daily life.
This study is testing whether using portable oxygen during physical activity can help people with mild-to-moderate interstitial lung disease feel better and be more active. It is for people whose oxygen levels drop during exercise but are normal at rest.
This trial tests a smart oxygen system that automatically adjusts oxygen levels for people with COPD who are in the hospital using a nasal high-flow device. It may help keep your oxygen levels stable without needing constant adjustments.
This trial compares using oxygen all the time (continuous) versus only when needed (demand-based) in people with fibrotic interstitial lung disease or COPD. It aims to find out which approach works better for daily life.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.